More tools:Markets·Screener·Research·Chat

Nkarta, Inc. Common Stock (NKTX) Financial Statements

Nkarta, Inc. Common Stock
SIC 2834 · PHARMACEUTICAL PREPARATIONS
FIGI BBG00JXHS9H6
XNAS · usd
3.23▲ 0.31 (10.62%)
As of 2026-09-08
Valuation
Market Cap
Enterprise Value
Trailing P/E—
Price / Sales—
EV / Revenue—
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin—
Net Debt
Trading Information
Previous Close2.92
Day's Range2.80 – 3.30
52-Week Range1.70 – 3.72
Volume1.5M
Avg Volume591.3K
Share Statistics
Shares Outstanding
Employees108
ExchangeXNAS
Listed2020-07-10
Share count as of August 5, 2026
Loading Income Statement…
Key questions about Nkarta, Inc. Common Stock (NKTX)
What is Nkarta, Inc. Common Stock's Market Cap?
Nkarta, Inc. Common Stock's Market Cap is $231.3M, based on as-reported figures from SEC (XBRL) filings.
What is Nkarta, Inc. Common Stock's Enterprise Value?
Nkarta, Inc. Common Stock's Enterprise Value is $48.6M, based on as-reported figures from SEC (XBRL) filings.
What is Nkarta, Inc. Common Stock's EV / EBITDA?
Nkarta, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Nkarta, Inc. Common Stock's Revenue (TTM)?
Nkarta, Inc. Common Stock's Revenue (TTM) is $0.00, based on as-reported figures from SEC (XBRL) filings.
What is Nkarta, Inc. Common Stock's Net Income (TTM)?
Nkarta, Inc. Common Stock's Net Income (TTM) is -$117.3M, based on as-reported figures from SEC (XBRL) filings.
What is Nkarta, Inc. Common Stock's EBITDA?
Nkarta, Inc. Common Stock's EBITDA is -$122.6M, based on as-reported figures from SEC (XBRL) filings.
What is Nkarta, Inc. Common Stock's Diluted EPS (TTM)?
Nkarta, Inc. Common Stock's Diluted EPS (TTM) is -1.64, based on as-reported figures from SEC (XBRL) filings.
What is Nkarta, Inc. Common Stock's Net Debt?
Nkarta, Inc. Common Stock's Net Debt is -$182.8M, based on as-reported figures from SEC (XBRL) filings.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Operating expenses:
Research and development
General and administrative
Total operating expenses
Loss from operations
Other income, net:
Interest income
Other income, net
Total other income, net
Net loss
Net loss per share, basic
Net loss per share, diluted